Scholarlink

<p>Tongue squamous cell carcinoma (TSCC) is a major subtype of head and neck cancer with limited treatment regimens. This paper examined phospholipid scramblase 1 (PLSCR1) and forkhead box protein A1 (FOXA1) expression patterns and function in TSCC progression. Abnormally high expression of <i>PLSCR1</i> was screened by the GEO datasets, and PLSCR1 expression in TSCC cells was verified. The upstream mechanism of abnormally elevated <i>PLSCR1</i> was investigated by bioinformatics analysis, and FOXA1 expression in TSCC cells was detected. The interaction between FOXA1 and the <i>PLSCR1</i> promoter in cells was detected by chromatin immunoprecipitation and dual-luciferase assay. The TSCC cell malignant phenotype was examined after different lentiviral vector treatments. Xenograft tumors were induced in mice to verify the mechanism. PLSCR1 was highly expressed in TSCC, while FOXA1 was downregulated. <i>PLSCR1</i> knockdown inhibited TSCC cell proliferation, migration, and invasion, and upregulated apoptosis. Ectopic expression of <i>FOXA1</i> repressed the malignant behaviors of TSCC cells. FOXA1 was enriched in the <i>PLSCR1</i> promoter in TSCC cells, and FOXA1 transcriptionally inhibited <i>PLSCR1</i> expression. In rescue experiments, overexpression of <i>FOXA1</i> inhibited TSCC progression, and this could be reversed by overexpression of <i>PLSCR1</i>. Overall, FOXA1 prevents TSCC progression through transcriptional repression of <i>PLSCR1</i>.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

FOXA1 Transcriptional Repression of PLSCR1 Inhibits Tongue Squamous Cell Carcinoma Progression

  • 期刊论文

  • 发表日期：

    2025年5月30日

查看全文
  • Jinxin Wang,
  • Cong Zhang,
  • Junrong Wang,
  • Lei Wang,
  • Li Liu,
  • Chunbin Duan

摘要

Tongue squamous cell carcinoma (TSCC) is a major subtype of head and neck cancer with limited treatment regimens. This paper examined phospholipid scramblase 1 (PLSCR1) and forkhead box protein A1 (FOXA1) expression patterns and function in TSCC progression. Abnormally high expression of PLSCR1 was screened by the GEO datasets, and PLSCR1 expression in TSCC cells was verified. The upstream mechanism of abnormally elevated PLSCR1 was investigated by bioinformatics analysis, and FOXA1 expression in TSCC cells was detected. The interaction between FOXA1 and the PLSCR1 promoter in cells was detected by chromatin immunoprecipitation and dual-luciferase assay. The TSCC cell malignant phenotype was examined after different lentiviral vector treatments. Xenograft tumors were induced in mice to verify the mechanism. PLSCR1 was highly expressed in TSCC, while FOXA1 was downregulated. PLSCR1 knockdown inhibited TSCC cell proliferation, migration, and invasion, and upregulated apoptosis. Ectopic expression of FOXA1 repressed the malignant behaviors of TSCC cells. FOXA1 was enriched in the PLSCR1 promoter in TSCC cells, and FOXA1 transcriptionally inhibited PLSCR1 expression. In rescue experiments, overexpression of FOXA1 inhibited TSCC progression, and this could be reversed by overexpression of PLSCR1. Overall, FOXA1 prevents TSCC progression through transcriptional repression of PLSCR1.